Literature DB >> 15001809

Role of neurotrophic factors in the etiology and treatment of mood disorders.

Ronald S Duman1.   

Abstract

Basic research in rodents has demonstrated that exposure to stress decreases levels of brain-derived neurotrophic factor (BDNF) in brain regions associated with depression. In contrast, antidepressant treatment produces the opposite effect and blocks the effects of stress on BDNF. BDNF upregulation and possibly other neurotrophic/growth factors could reverse or block the atrophy and cell loss that has been observed in rodent stress models and in depressed patients. The morphological alterations observed in depressed patients could result from decreased size or number of glia and/or neurons and may include regulation of adult neurogenesis. This article reviews the primary work leading to a neurotrophic hypothesis of depression and antidepressant action and the cellular mechanisms and signal transduction pathways that underlie these effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001809     DOI: 10.1385/NMM:5:1:011

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  84 in total

1.  Neuronal plasticity and survival in mood disorders.

Authors:  R S Duman; J Malberg; S Nakagawa; C D'Sa
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

2.  Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers.

Authors:  M A Smith; L X Zhang; W E Lyons; L A Mamounas
Journal:  Neuroreport       Date:  1997-05-27       Impact factor: 1.837

3.  Increased temporal cortex CREB concentrations and antidepressant treatment in major depression.

Authors:  D Dowlatshahi; G M MacQueen; J F Wang; L T Young
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

4.  Regulation of GFRalpha-1 and GFRalpha-2 mRNAs in rat brain by electroconvulsive seizure.

Authors:  A C Chen; A J Eisch; N Sakai; M Takahashi; E J Nestler; R S Duman
Journal:  Synapse       Date:  2001-01       Impact factor: 2.562

5.  Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation.

Authors:  C A Murray; M A Lynch
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

6.  Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus.

Authors:  M Roceri; W Hendriks; G Racagni; B A Ellenbroek; M A Riva
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

7.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

8.  Hippocampal atrophy in recurrent major depression.

Authors:  Y I Sheline; P W Wang; M H Gado; J G Csernansky; M W Vannier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

9.  Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus.

Authors:  Ritsuko Katoh-Semba; Tomiko Asano; Hiroshi Ueda; Rika Morishita; Ikuo K Takeuchi; Yutaka Inaguma; Kanefusa Kato
Journal:  FASEB J       Date:  2002-06-21       Impact factor: 5.191

10.  Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain.

Authors:  L A Mamounas; M E Blue; J A Siuciak; C A Altar
Journal:  J Neurosci       Date:  1995-12       Impact factor: 6.167

View more
  144 in total

1.  Extracellular signal-regulated kinase 2 signaling in the hippocampal dentate gyrus mediates the antidepressant effects of testosterone.

Authors:  Nicole Carrier; Mohamed Kabbaj
Journal:  Biol Psychiatry       Date:  2012-01-20       Impact factor: 13.382

Review 2.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

3.  Supplemental dietary choline during development exerts antidepressant-like effects in adult female rats.

Authors:  Melissa J Glenn; Raven S Adams; Lauren McClurg
Journal:  Brain Res       Date:  2012-01-17       Impact factor: 3.252

4.  A chronobiological perspective on ketamine's antidepressant efficacy.

Authors:  Giandomenico Schiena; Edoardo Giuseppe Ostinelli; Orsola Gambini; Armando D'Agostino
Journal:  Psychopharmacology (Berl)       Date:  2015-08-06       Impact factor: 4.530

Review 5.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

6.  Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood.

Authors:  Brandon L Warren; Sergio D Iñiguez; Lyonna F Alcantara; Katherine N Wright; Eric M Parise; Sarah K Weakley; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

Review 7.  Exercise, learned helplessness, and the stress-resistant brain.

Authors:  Benjamin N Greenwood; Monika Fleshner
Journal:  Neuromolecular Med       Date:  2008-02-26       Impact factor: 3.843

Review 8.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

9.  Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise.

Authors:  Catharine H Duman; Lee Schlesinger; Rosemarie Terwilliger; David S Russell; Samuel S Newton; Ronald S Duman
Journal:  Behav Brain Res       Date:  2008-11-14       Impact factor: 3.332

10.  Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission.

Authors:  Brian A Hoshaw; Tiffany I Hill; James J Crowley; Jessica E Malberg; Xavier Khawaja; Sharon Rosenzweig-Lipson; Lee E Schechter; Irwin Lucki
Journal:  Eur J Pharmacol       Date:  2008-07-17       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.